Clinical trial

Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung Cancer

NCT00934076

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2010-02-01

PhasePHASE1

Study timeline

Study start (unknown)2010-02-01Date precision: month

Registry last updated2015-05-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carcinoma, Non Small Cell Lungunresolved

Interventions

Tarceva plus AT-101DRUG

Sponsors & collaborators

University of Alabama at Birminghamlead sponsor

Ascenta Therapeuticscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00934076 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.